Page last updated: 2024-09-04

cryptotanshinone and ER-Negative PR-Negative HER2-Negative Breast Cancer

cryptotanshinone has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cai, G; Chen, C; Guo, J; Kong, L; Li, S; Yin, G; Yu, W; Zhang, C; Zhang, W; Zhu, J	1

Other Studies

1 other study(ies) available for cryptotanshinone and ER-Negative PR-Negative HER2-Negative Breast Cancer

Article	Year
A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy. Cell death & disease, 2018, 10-27, Volume: 9, Issue:11 Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Phenanthrenes; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; STAT3 Transcription Factor; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays	2018

Article

Year

A new synthetic derivative of cryptotanshinone KYZ3 as STAT3 inhibitor for triple-negative breast cancer therapy.

Cell death & disease, 2018, 10-27, Volume: 9, Issue:11

Topics: Active Transport, Cell Nucleus; Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Phenanthrenes; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; STAT3 Transcription Factor; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2018